A detailed history of Sutton Wealth Advisors Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 3 shares of BIO stock, worth $890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 3 -0.0%
Holding current value
$890
Previous $1.14 Million 5.45%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 07, 2023

SELL
$351.71 - $456.01 $2,813 - $3,648
-8 Reduced 72.73%
3 $1.26 Million
Q3 2022

Nov 07, 2023

BUY
$412.59 - $563.26 $825 - $1,126
2 Added 22.22%
11 $4.59 Million
Q2 2022

Nov 07, 2023

BUY
$463.67 - $597.16 $3,709 - $4,777
8 Added 800.0%
9 $4.46 Million
Q1 2022

Nov 07, 2023

BUY
$524.57 - $735.42 $524 - $735
1 New
1 $563,000
Q4 2021

Nov 07, 2023

SELL
$708.84 - $794.68 $2,126 - $2,384
-3 Closed
0 $0
Q3 2021

Nov 07, 2023

BUY
$657.71 - $825.77 $1,973 - $2,477
3 New
3 $2.24 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.31B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.